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The endothelial cell surface layer (ESL) is believed to
contribute to the glomerular barrier, and the nature of its
molecular structure is still largely unknown. The ESL consists
of the membrane-bound glycocalyx and the loosely attached
endothelial cell coat (ECC). A brief injection of hypertonic
sodium chloride into the left renal artery was used to
displace, elute, and collect non-covalently bound
components of the renal ESL in rats. This procedure increased
the fractional clearance of albumin 12-fold without
detectable morphological changes as assessed by electron
microscopy compared with the control group injected with
isotonic saline. Mathematical modeling suggested a reduced
glomerular charge density. Mass spectrometry of the renal
eluate identified 17 non-covalently bound proteins normally
present in the ECC. One of these proteins, orosomucoid, has
previously been shown to be important for capillary
permselectivity. Another protein, lumican, is expressed by
glomerular endothelial cells and likely contributes to
maintaining an intact barrier. Thus, the absence of one or
more of these proteins causes proteinuria and illustrates the
importance of the ECC in glomerular permselectivity.
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Accumulation of proteins in the urine is a key feature of renal
disease and a consequence of an impaired glomerular
filtration barrier. The glomerular filtration barrier is a
biological membrane that includes a unique type of the
fenestrated endothelium mainly without diaphragms covered
with a glycoprotein surface layer, a glomerular basement
membrane (GBM), and podocytes with foot processes
bridged by slit diaphragms.1 The permselectivity of this
barrier has been considered to reside principally in the GBM
and in the podocyte slit diaphragm, whereas fenestrated
endothelial cells and the endothelial cell surface layer (ESL)
have attracted lesser attention. Nevertheless, the classical view
of the GBM as a major contributor to the permselectivity
of the glomerular barrier has been challenged,2–5 and a
decade of extensive research regarding the podocytes has
given important information about numerous proteins of the
slit diaphragm that can cause proteinuria when defective.6–8
Simultaneously, experimental evidence has accumulated for
the presence of a permselective cell surface layer covering the
luminal face of glomerular endothelial cells.9–13 In the end of
the 1980s, perfusion of the rat kidneys with cationic, anionic,
or neutral ferritin demonstrated that cationic ferritin bound
to, and visualized, a protein coat that covered the glomerular
endothelium.14–16 Rostgaard and Qvortrup,17,18 using a
different method of vascular perfusion fixation, found
evidence for an extensive protein coat on the surface and in
the fenestrae of the glomerular endothelium. Furthermore,
we revealed a 200-nm-thick ESL stretching into the capillary
lumen.19 In mice treated with adriamycin, the thickness of
this layer was markedly reduced, an effect coinciding with the
development of proteinuria and impaired synthesis of certain
components of the ESL.20 Another study in mice demon-
strated that infusion of enzymes that specifically degrade
glycosaminoglycans reduced the thickness of the ESL and
increased fractional clearance for albumin.21 Others have
performed in vitro studies of the passage of albumin across
monolayers of human glomerular endothelial cells and have
observed an increased albumin flux after treatment with
human heparanase.22 There is also clinical evidence that
suggests that damage to the glomerular endothelium can
cause proteinuria in pre-eclampsia and hemolytic uremic
syndrome.23,24
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The ESL has two components. First, there is the
glycocalyx, which is composed of membrane-bound proteo-
glycans (PGs). Second, attached to the glycocalyx, there is
the endothelial cell coat (ECC), composed of secreted
PGs, glycosaminoglycans, glycoproteins, and plasma pro-
teins.1,25,26 The abundant, negatively charged PGs and
glycosaminoglycans are believed to capture circulating
plasma proteins and to produce a thick mesh with anionic
properties in a gel-like structure.27,28 In previous studies, we
have shown that the plasma protein orosomucoid is required
for maintaining normal glomerular permeability in rats.29,30
The aim of this study was to provide more information on
the ECC, including its permselective properties and its
composition. Our approach was to establish a mild in vivo
method for displacing non-covalently bound ECC compo-
nents and to subsequently collect them for further character-
ization. A brief intrarenal high-salt (HS) perfusion through
the renal artery was performed to displace anionic non-
covalently bound components according to the principles
of ion-exchange chromatography. A similar principle was
previously used in an isolated perfused rat kidney system
using low- and high-ionic strength in which we could
modulate fractional clearances of albumin in a very specific
and reversible manner.27,28
RESULTS
Morphological evaluation of the glomerular filtration barrier
Morphological examination with electron microscopy of
kidney sections obtained from animals perfused with
0.15mol/l NaCl (normal salt, NS) and 1mol/l NaCl (HS)
confirmed that the overall architecture of the glomerular
filtration barrier remained morphologically normal during
treatment (Figure 1). In addition, to quantitatively assess the
condition of the filtration barrier, GBM thickness, podocyte
foot process width, and width of filtration slits were
measured in glomerular capillaries from animals perfused
with NS and HS. The morphometric measurements revealed
small but statistically significant differences between the two
experimental groups (Table 1).
Effects on GFR
When measured 10 and 20min after HS perfusion, the
glomerular filtration rate (GFR) was significantly reduced
by 34±8.7% and 23±7.7% (P o0.001, P o0.01, n¼ 10),
respectively, relative to the pre-perfusion mean. GFR then
started to recover toward the pre-perfusion level. No changes
were seen in the NS group; for further details, see Figure 2.
The absolute mean values of pre-perfusion points (20 and
10min) were 1.21±0.089 and 1.19±0.073 for the NS
group and 0.96±0.058 and 1.05±0.053 for the HS group
(ml/min per g kidney wet weight).
Functional effects on the glomerular filtration barrier
In rats perfused with HS, the fractional clearance for albumin
increased B12-fold relative to both baseline and NS when
measured 10min after perfusion (Figure 3). This was followed
by a slow but significant recovery over the subsequent 90min
(Po0.05, log-linear regression analysis), but the fractional
albumin clearance remained significantly higher in the HS
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Figure 1 | Electron micrographs illustrating the glomerular
filtration barrier after perfusion with salt solution. The rat
kidneys were perfused with 0.15mol/l NaCl (normal salt, NS) in
(a) control animals and with 1mol/l NaCl (high salt, HS) in (b)
treated animals. Micrographs demonstrate a normal
morphological appearance of the glomerular filtration barrier in
both groups. Original magnification  8000. BM, basement
membrane; CL, capillary lumen; EC, endothelial cell; FP, foot
process; HS, high salt; NS, normal salt; US, urinary space.
Table 1 | Summary of morphometric measurements of
various structures in the glomerular filtration barrier
NS HS
Glomerular basement membrane
thickness (nm)
168.57±1.31 174.14±1.15**
Podocyte foot process width (nm) 301.49±7.54 307.38±7.58
Podocyte filtration slit width (nm) 40.63±0.37 38.23±0.41***
Endothelial cell surface layer
thickness (nm)
123.42±8.06 123.81±8.49
Abbreviations: HS, high salt; NS, normal salt.
Data are means±s.e.m. **Po0.01, ***Po0.001, n=52 glomeruli from 4 NS animals,
n=60 glomeruli from 4 HS animals.
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Figure 2 |Alterations of the glomerular filtration rate (GFR).
On the x axis, 20 and 10 are pre-perfusion points, the time
registration starts at perfusion and continues for 100min. The GFR
was significantly reduced in HS (high salt, 1mol/l NaCl) animals, 10
and 20min post perfusion relative to the pre-perfusion mean.
Changes are expressed as percentages of the mean value of the
two pre-perfusion points. Data represent means±s.e.m., n¼ 10 in
HS rats, except for 80 and 100min (n¼ 9) and in NS (normal salt,
0.15mol/l NaCl) rats, n¼ 10, except for 40 and 80min (n¼ 9) and
100min (n¼ 8). **P o0.01, ***P o0.001.
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group throughout the 100-min observation period. The
fractional albumin clearance remained normal in the NS group
throughout the measurement period (n¼ 7–10).
The fractional clearance for Ficoll 35.5 A˚ (uncharged, size
corresponding to albumin) was measured in HS and NS rats,
and there were no significant alterations after salt perfusion
(Figure 4). The fractional clearance for Ficoll 55 A˚ (a measure
of the large pore fraction) was significantly increased 4-fold
in HS-perfused rats 10min after perfusion compared with
the pre-perfusion value (P o0.001, n¼ 8, Figure 5). Ficoll
55 A˚ clearance was unaffected in NS-perfused rats.
Results of mathematical modeling
Alterations to the barrier were analyzed using two separate
models, and similar results were found with both models.
The most advanced model is the heterogeneous charged fiber
model according to which there was a 56% reduction in fiber
net charge (Po0.001, n¼ 8) after a short perfusion with HS
compared with NS (Table 2).1,21 The number of large pores
increased five-fold (Po0.05, n¼ 8), whereas the reduction in
fiber volume fraction was non-significant. The gel membrane
model showed that the kidneys of HS-perfused rats had an
increase in large pores (Po0.01, n¼ 8) and a reduced charge
density (P o0.001, n¼ 8); see Table 3.31
Effects on the thickness of the ESL
The thickness of ESL was estimated using Intralipid droplets
as indirect markers (Figure 6).20 Measurement of the distance
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Figure 3 |Measurements of fractional albumin clearance in
rats before and after salt perfusion. On the x axis, 20 and 10
are pre-perfusion points, and the time registration starts at
perfusion and continues for 100min. There is significant
difference between HS (high salt, 1mol/l NaCl) rats relative to
baseline in all post-perfusion points. Data represent
means±s.e.m., n¼ 10 in NS (normal salt, 0.15mol/l NaCl) rats,
except for 100min (n¼ 7) and in HS rats, n¼ 9, except for 80 and
100min (n¼ 8). **P o0.01, ***P o0.001.
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Figure 4 |Analysis of the fractional clearance of Ficoll 35.5 A˚
before and after salt perfusion in rats. On the x axis, 10 is a
pre-perfusion point and the zero point is where perfusion occurs,
followed by two post-perfusion points. Data represent
means±s.e.m., n¼ 8 in HS (high salt, 1mol/l NaCl) rats and n¼ 8
in NS (normal salt, 0.15mol/l NaCl) rats, except for 20min (n¼ 7).
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Figure 5 |Analysis of the fractional clearance of Ficoll 55 A˚
before and after salt perfusion in rats. On the x axis, 10 is a
pre-perfusion point and the zero point is where perfusion occurs,
followed by two post-perfusion points. Statistical analysis was
made by comparing the post-perfusion fractional Ficoll clearance
in HS (high salt, 1mol/l NaCl) rats with the pre-perfusion value.
Data represent means±s.e.m., n¼ 8 in HS rats and n¼ 8 in NS
(normal salt, 0.15mol/l NaCl) rats, except for 20min (n¼ 7). ***P
o0.001.
Table 2 | Summary of mathematical modeling using the
heterogeneous charged fiber matrix model
Normal salt HS P-value
Fiber radius (A˚) 5.00±0.00 5.00±0.00 NS
Fiber volume fraction (%) 5.21±0.08 4.91±0.14 NS
Large pore LpS (%) 0.020±0.003 0.100±0.038 o0.05
Fiber net charge (C/m2) 0.375±0.03 0.166±0.02 o0.001
Meas/calc albumin (%) 25±11 49±13 NS
Abbreviations: C/m2, Coulomb/meter squared; HS, high salt; LpS, total hydraulic
conductance; Meas/calc, measured/calculated; NS, not significant.
Data are means ± s.e.m., n=8.
Table 3 | Summary of mathematical modeling using the gel
membrane model
Normal salt HS P-value
Small pore radius (A˚) 49.7±0.36 50.2±1.25 NS
Large pore radius (A˚) 79.2±2.48 81.8±7.33 NS
Large pore LpS (%) 0.50±0.11 1.35±0.78 o0.01
Charge density (mEq/l) 86.8±3.06 64.8±3.61 o0.001
Abbreviations: HS, high salt; LpS, total hydraulic conductance; NS, not significant.
Data are means±s.e.m., n=8.
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between lipid droplets and the endothelial cell membrane in
rats perfused with HS and NS demonstrated that there was
no significant difference of the thickness of the ESL between
the groups (Table 1).
Mass spectrometry analysis of renal eluates
To examine displaced proteins from the ESL, eluates from
both groups were immunodepleted and analyzed with liquid
chromatography-mass spectrometry using an LTQ-Orbitrap.
Two independent runs, using different settings but the same
original material identified in total 67 proteins in the NS
eluate, 93 proteins in the HS eluate, and 93 proteins in the rat
plasma. The total number of unique peptides was 1993, 1847,
and 2933 in the HS eluate, NS eluate, and plasma,
respectively. The overlap of identified proteins is shown in
a Venn diagram (Figure 7). Peptide counting was used
as a semi-quantitative method. Proteins were selected from
the total number of identified proteins in Figure 7 according
to the following inclusion criteria and are presented in
Tables 4–6: proteins found in the HS eluate in both runs, in
which the number of identified peptides assigned to the
protein was at least 2 times higher compared with the NS
eluate (Table 4) (8 proteins out of 63); proteins found in the
HS eluate and the plasma in both runs, but not found in the
NS eluate (Table 5) (3 proteins out of 11); and proteins found
exclusively in the HS eluate and in both runs (Table 6)
(6 proteins out of 19). The molecular weight range of
proteins displayed in Tables 4–6 was 5–190 kDa. An absolute
quantification was performed with unique peptides for
lumican using selected reaction monitoring with respective
AQUA peptides. The peptide ITNIPDEYFNR produced an
HS/NS ratio of 2.3 based on peak area when compensating
for the spike in the AQUA peptide (7278/1174781)/(2967/
1089557), and the peptide FTGLQYLR produced an HS/NS
ratio of 3.2 (15915/1356854)/(4610/1155172) (Figure 8). A
third peptide (ILGPLSYSK) produced an HS/NS ratio of 3.4
without AQUA peptide compensation, resulting in an average
HS/NS ratio for lumican of 3.0. Supplementary Figure S1
online illustrates the spectrum signatures of the AQUA
peptides (A, B) and the quantification of the ILGPLSYSK
peptide (C). Two other examples for selected reaction
monitoring quantification without using AQUA peptides
are shown for glutathione peroxidase 3 and gelsolin, which
produced HS/NS ratios of 3.7 and 1.2, respectively (see
Supplementary Table S1 online).
Immunohistochemical analysis of lumican
To confirm that lumican is present in the glomerular capillary
endothelium, we performed immunohistochemical analysis
in cryosections of the human kidney tissue. For additional
evidence about the localization, we performed colocalization
studies with the endothelial-specific lectin rhodamine Ulex
europaeus agglutinin I. There was a clear colocalization of
lumican with this endothelial-specific marker in the glomer-
ular capillary endothelium (Figure 9).
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Figure 6 |A magnification of the glomerular capillary wall,
indicating the procedure for estimations of various structures
in the filtration barrier. The inset shows an overview of the
glomerular capillary from which the magnification was taken.
The white lines from left to right indicate the measuring position
for podocyte filtration slit width, basement membrane thickness,
podocyte foot process width, and thickness of the endothelial cell
surface layer (ESL). The width of podocyte filtration slits was
assessed by measuring the slit diaphragms interconnecting the
foot processes. The thickness of the basement membrane was
measured perpendicular to the podocyte slit diaphragm and the
plasmalemma of adjacent endothelial cells. The width of the
podocyte foot processes was measured linearly at the base of the
foot processes, following interface with the basement membrane.
The thickness of the ESL was determined by measuring the
distance of the lipid droplet closest to and within 500 nm from the
endothelial cell membrane. BM, basement membrane;
CL, capillary lumen; EC, endothelial cell; FP, foot process;
ILD, intralipid droplet; US, urinary space.
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Figure 7 |Venn diagram showing the distribution of the total
number of identified proteins in the plasma, HS eluate, and
NS eluate, using liquid chromatography-mass spectrometry.
Merged plasma samples, merged HS (high salt, 1mol/l NaCl)
eluates, and merged NS (normal salt, 0.15mol/l NaCl) eluates from
three rats in each group were processed, run on an LTQ-Orbitrap,
and protein identities were analyzed using ProteinCenter (Thermo
Fisher Scientific, Waltham, MA).
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DISCUSSION
The main contribution of this study is the identification of
novel components of the ECC, which seem to be required for
normal glomerular barrier function. The tool for acquiring
the data was a new in vivo method, developed for studying
the ECC without using any noxious chemical agents. The
method, consisting of a short perfusion with 1mol/l NaCl,
uses the basic principles of ion-exchange chromatography.
Non-covalently and loosely attached components of the ESL
are displaced when the kidney is perfused briefly with the
high-ionic strength NaCl solution. In this study, we focused
on medium-sized plasma proteins and small PGs as the
perfusion time was too short to allow for diffusion of large
proteins or large PGs. HS perfusion gave rise to an increased
fractional albumin clearance, indicating a reduced charge
selectivity of the glomerular filtration barrier. Size selectivity
also was affected to some extent. The proteinuria following
HS perfusion was reversible, as seen by the 50% recovery of
fractional albumin clearance in the first hour after perfusion,
but the fractional albumin clearance did not return to the
pre-perfusion level during the observation period. The
observed recovery of the fractional albumin clearance in
HS-perfused rats could depend on re-enrichment of
circulating plasma proteins in the ESL when the ionic
strength normalizes. Potentially re-enriched proteins in the
ESL are those that we found in the HS eluate and plasma
(Table 5), including the last three proteins in Table 4. One of
these proteins, orosomucoid, has previously been shown to
be essential for the maintenance of normal permeability in
peripheral capillaries.29,30,32–34
A reason for the fractional albumin clearance remaining
high 1 h after HS injection could be that components lost
from the ECC need to be synthesized and secreted by
glomerular endothelial cells. The PG lumican may be one
such component; it was identified together with four other
proteins, in significantly higher concentration in the HS
eluate compared with the NS eluate, but not present in the
plasma (Table 4). Lumican was also immunolocalized and
found to be colocalized with an endothelial-specific marker
in the glomerular capillary endothelium of kidney sections
(Figure 9). Lumican belongs to the family of small leucine-
rich repeat PGs that constitutes an important fraction of
non-collagenous extracellular matrix proteins.35 The expres-
sion of lumican in the kidney has been observed by our group
(unpublished array data) and reported elsewhere.36 We
identified 11 peptides assigned to lumican in the HS eluate
versus 3 in the NS eluate (HS/NS ratio of 3.7), with a ratio of
3.0 with the selected reaction monitoring assay. We also
performed selected reaction monitoring on other identified
proteins without applying AQUA peptides, and the HS/NS
ratios were similar as with the Orbitrap analysis shown in
Tables 4–6. Two examples are glutathione peroxidase 3 and
gelsolin (Supplementary Table S1 online). This supports the
semi-quantitative approach of counting peptides identified
by the LTQ-Orbitrap and validates the peptide counting
ratios for other proteins.
Furthermore, we identified proteins that were found only
in the HS eluate (Table 6). A review of a substantial number
Table 4 | Proteins found in the HS eluate in two runs, in which the number of identified peptides assigned to the protein was at
least two times higher compared with the NS eluate
Name Accession number nP_HS nP_NS nP_plasma nP_HS/np_NS
Lumican P51886 11 3 — 3.7
Glutathione peroxidase 1 P04041 4 1 — 3.7
Thymosin b-4 P62329 3 1 — 2.8
14-3-3 protein zeta/d P63102 5 2 — 2.5
Peptidyl-prolyl cis-trans isomerase A P10111 7 3 — 2.3
Glutathione peroxidase 3 P23764 22 3 21 7.3
Gelsolin Q68FP1 12 4 17 3.0
Complement C4 P08649 8 4 62 2.0
Abbreviations: HS, high salt; nP, number of unique peptides assigned to displayed proteins; NS, normal salt.
Merged plasma, merged HS, and merged NS eluate from three rats processed and run on an LTQ-Orbitrap, followed by analysis by Proteome Discoverer (Thermo Fisher
Scientific), ProteinCenter, and MS Excel 2007 (Microsoft AB, Kista, Sweden).
Table 5 | Proteins found in the HS eluate and the plasma in
two runs, not found in the NS eluate
Name
Accession
number nP_HS nP_plasma
a-1-Acid glycoprotein (orosomucoid) P02764 5 9
Complement component C9 Q62930 5 10
Hepatic triacylglycerol lipase P07867 3 5
Abbreviations: HS, high salt; nP, number of unique peptides assigned to displayed
proteins; NS, normal salt.
Merged plasma, merged HS, and merged NS eluate from three rats processed and
run on an LTQ-Orbitrap followed by analysis by Proteome Discoverer, ProteinCenter,
and MS Excel 2007.
Table 6 | Proteins found in the HS eluate in two runs, not
found in the NS eluate or the plasma
Name Accession number nP_HS
Peroxiredoxin-1 Q63716 4
a-Actinin-1 Q9Z1P2 3
Heat-shock cognate 71-kDa protein P63017 3
Profilin-1 P62962 3
Cytochrome b–c1 complex subunit 2 P32551 2
Annexin A5 P14668 2
Abbreviations: HS, high salt; nP, number of unique peptides assigned to displayed
proteins; NS, normal salt.
Merged plasma, merged HS, and merged NS eluate from three rats processed and
run on an LTQ-Orbitrap, followed by analysis by Proteome Discoverer, ProteinCen-
ter, and MS Excel 2007.
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of comparative proteomic studies by Wang et al.37 revealed
that proteins from 28 different protein families were
frequently detected, regardless of species, in vivo or in vitro
conditions, tissues and organs, and experimental objective.
The authors suggested that cellular stress response can be the
common reason why particular proteins are generally
expressed. Three proteins (namely Peroxiredoxin-1, Heat-
shock cognate 71-kDa protein, and Annexin A5) from Table 6
belong to the group of frequently detected protein families.
When we performed the morphological evaluation, we found
no ultrastructural abnormalities that would suggest a leaky
barrier after HS perfusion. On the contrary, electron
microscopy revealed a 3% increase in GBM thickness and a
5% reduction in podocyte filtration slit width and, if
anything, these changes would be expected to make the
barrier slightly tighter and reduce albumin clearance.
Possibly, the HS solution induced a contraction of podocytes
and/or affected the GBM per se. Furthermore, we looked at
the glomerular ESL thickness with a method developed in
our laboratory using electron microscopy and Intralipid
droplets.19 The thickness of the ESL was expected to diminish
after HS perfusion as seen after enzymatic digestions of the
ESL in mice.21 However, no difference was seen between the
two groups. A likely explanation is that enzymes used in
previous studies digest the membrane-bound PGs that
constitute the framework of the ESL, whereas salt perfusion
rather elutes specific non-covalently bound molecules leaving
a more intact ESL meshwork. In addition, the HS solution
was injected as a short-lasting (15 s) 1-ml bolus compared
with the much longer enzyme treatment.
The total vascular surface area in the kidney is completely
dominated by the capillaries, whereas the arteries and veins
constitute only a minor fraction. Thus, proteins eluted in this
study are considered to come from the ESL of the glomerular
and/or the peritubular capillaries. The temporal coincidence
of increased albumin leakage with the elution of certain
proteins and the colocalization of lumican with the
glomerular endothelium strongly support that we study
effects specifically in the glomerular ESL.
The mathematical modeling is consistent with the
interpretation that injection of 1ml of 1mol/l NaCl eluted
‘charged fibers’ from the barrier. Thus, according to both the
gel-membrane model and the more advanced charged fiber
model, HS injection reduced the glomerular charge density
while leaving the size selectivity largely unaffected, except for
the largest solutes. The perfusion procedure used here is mild
as revealed by the modest effects on GFR and the reversibility
of albuminuria. The kidney wet weights were identical in
both groups, and the transient reduction in GFR during the
first 20min after HS perfusion is most probably caused by
vasoconstriction of afferent arterioles, due to HS concentra-
tion.38 One could argue that reduced GFR would elevate
albumin clearance per se, as the lower rate of fluid transport
across the barrier allows time for more albumin to diffuse
into the urinary space for a given amount of fluid filtrated.
However, this phenomenon has been studied for neutral
Ficoll in the same size of albumin and the clearance increased
B10% in the GFR interval of this study.39,40 For anionic
albumin, this effect would be even smaller. HS perfusion
increased albumin clearance by more than one order of
magnitude; hence, the impact of transiently reduced GFR on
albumin clearance is insignificant in this study.
To conclude, using a new, ion-exchange-based in vivo
technique for analyzing the composition of the capillary ESL
and in particular its cell coat, we have, so far, identified
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Figure 8 |Absolute quantification of lumican using selected
reaction monitoring (SRM) assay. Two peptides unique for
lumican were quantified in merged HS (high salt, 1mol/l NaCl)
and merged NS (normal salt, 0.15mol/l NaCl) eluates using SRM
assay designed on the basis of respective AQUA peptide
standards. The unique SRM spectra are shown in the upper right
corners of the figure and the corresponding SRM spectra from the
AQUA peptides are shown in Supplementary Figure S1 online.
The most abundant transition was used for quantification based
on the peak area and the other transitions for peptide
genuineness and assay verification. (a) The peptide ITNIPDEYFNR
with m/z¼ 691.4 (z¼ 2) and its transition to m/z¼ 940.5 (z¼ 1)
was used for quantification, and five other transitions (m/
z¼ 720.4, 843.4, 1053.6, 1167.6, and 1268.7) were used for
verification. (b) FTGLQYLR, with m/z¼ 499.3 (z¼ 2) to m/z¼ 749.5
(z¼ 1), was used for quantification, and three other transitions
(m/z¼ 579.4, 692.5, and 850.5) were used for verification. AQUA,
absolute quantification; counts, peptide counts; HS, high salt; m/z,
mass to charge; NS, normal salt; RT, retention time.
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17 proteins from the ECC. Some of these, like lumican, are
probably secreted by the endothelium, whereas others, such
as orosomucoid, are plasma proteins. Indeed orosomucoid
has previously been shown to be important for normal
capillary permeability.29,30
Owing to the nature of the intervention, that is, perfusion
of the entire renal vasculature with HS solution, at least some
of the eluted proteins could originate from the peritubular
capillary ESL, downstream of the glomerular capillaries, and
it is presently not possible to pinpoint the origin of
individual proteins. However, the much thicker glomerular
ECC, which is notoriously easy to lose during fixation for
histology, makes it likely that a substantial fraction of the
eluted material is of glomerular origin. In addition, in vivo
albumin clearance increased by one order of magnitude after
injection of 1ml HS solution, suggesting that one or more of
the eluted ECC proteins are essential for preserving an intact
glomerular barrier, and such proteins must reasonably be of
glomerular origin. In any case, the results presented here
clearly convey the message that even morphologically subtle
alterations of the glomerular ESL can cause clinically
significant proteinuria.
MATERIALS AND METHODS
General animal preparation
Female Sprague–Dawley rats (Harlan, Horst, The Netherlands) kept on
standard fodder and free access to water were used. Animal
experiments were endorsed by the local ethics review committee.
Anesthesia was induced and maintained by inhalation of
isoflurane (1.5–3% v/v, Isobavet, Schering-Plough Animal Health,
Buckinghamshire, UK) mixed with air (2.0 l/min) and oxygen (0.3 l/
min) in an isoflurane vaporizer (Ohmeda Isotec 5, Simtec Engineer-
ing, Askim, Sweden). Body temperature (37 1C) was preserved using a
thermostatically controlled heating pad, together with a heating lamp.
Experimental protocols
Protocol 1: Measurement of GFR. The left internal jugular vein
was used for administration of infusion solution with and without
tracers. The left carotid artery served as a route for perfusion of the
Lumican Ulex europaeus Merge
Lumican Ulex europaeus Merge
Figure 9 | Lumican is localized in the glomerular capillary endothelium and colocalizes with an endothelial-specific marker in the
healthy human kidney tissue. (a) Confocal microscopic images of cryosections show the localization of lumican in the glomerular capillary
endothelium (green) and the endothelial-specific lectin rhodamine Ulex europaeus agglutinin I (red). The colocalization of these proteins is
shown in Merge (yellow). (b) Magnifications ( 10) of one glomerular capillary loop from the image in panel a. (c) Omission of the primary
antibody caused no staining. Bar¼ 25mm in panel a and bar¼ 2.5 mm in panel b.
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kidney, for collection of arterial blood, and for registration of
arterial pressure using an electronic transducer (CODAN pvb
Critical Care GmbH, Forstinning, Germany). Animals were
eviscerated and the left ureter was cannulated for urine collections.
Arterial pressure and urine weight were monitored using AcqKnow-
ledge v3.7.3 (Biopac Systems, Goleta, CA) software. A priming dose
of 0.055MBq/ml 51Cr-EDTA and 700mg/l FITC (fluorescein
isothiocyanate)-Ficoll in the infusion solution was injected into
the jugular vein, followed by a continuous infusion of 0.015MBq/ml
51Cr-EDTA and 340mg/l FITC-Ficoll in the infusion solution at a
rate of 150ml/min throughout the experiment. Tracers were
equilibrated for 15min in the circulation, whereupon two sequential
collections of arterial blood and urine in 10-min durations were
performed for the estimation of GFR and fractional clearance for
albumin and Ficoll. A catheter in the carotid artery was advanced
through the abdominal aorta and fixed in the renal artery to restrict
perfusion to include only the kidney. The renal vasculature system
was perfused during 10–15 s with 1ml of 1mol/l NaCl (HS) or
0.15mol/ NaCl (NS) in control animals, followed by a brief flush
with 0.2ml of 0.15mol/l NaCl to remove all HS solutions. The
catheter was withdrawn and blood flow to the kidney restored. Two
sequential portions of blood and urine were collected in 5-min
durations 10 and 20min after perfusion, followed by 4 sequential
collections in 5-min durations and at 20-min intervals.
Protocol 2: Collection of the renal eluate for protein
identification. The left carotid artery again served as a route for
perfusion of the kidney and to maintain fluid balance. Animals were
eviscerated, small capillaries extending the renal vein were ligated, and
ligatures were prepared around both the renal artery and the renal vein
for closure and fixation of a collecting catheter. The catheter in the
carotid artery was then advanced through the abdominal aorta and the
following steps were performed consecutively and within B1.5min.
The catheter in the abdominal aorta was advanced and fixed in the
renal artery. The ligature around the renal vein in proximity of the vena
cava was ligated after a catheter was positioned for collection of the
renal vein eluate. The renal vasculature system was rinsed with 1ml of
0.15mol/l NaCl, perfused with 1ml of 1mol/l (HS group) or 0.15mol/l
(NS group) NaCl, and finally rinsed with 1ml of 0.15mol/l NaCl. The
effluent was collected through the venous catheter as three separate
eluates p1, p2, and p3. The hemoglobin concentration in each was
measured with a blood gas analyzer Radiometer ABL 725 (Radiometer
Medical Aps, Brønshøj, Denmark) to assess blood contamination.
Eluates p2 from three animals in each group were pooled for further
analysis with mass spectrometry.
Protocol 3: Assessment of renal morphology. The experi-
mental procedure was identical to protocol 1, with the exception
that functional measurements were not performed in these animals.
After perfusion of the kidney with HS or NS, 1.5ml of intralipid
solution was injected into the left jugular vein and allowed to
equilibrate in the circulation for 10min. The left renal artery and
vein was clamped and the kidney was fixed by subcapsular injection
of Karnovsky’s fixative and sliced as described earlier.19,41
Analysis of albumin, Ficoll, and 51Cr-EDTA in urine and
plasma samples
Albumin concentration was measured using a rat albumin enzyme-
linked immunosorbent assay according to the manufacturer’s
protocol (Bethyl Laboratories, Montgomery, TX). Determination
of FITC-Ficoll of different radii and g-radiation of 51Cr-EDTA were
analyzed according to previous work.20
Indirect immunofluorescence and confocal microscopy
Cryosections of the nephrectomized healthy human kidney tissue
were blocked with 2% fetal calf serum and 2% bovine serum
albumin in phosphate-buffered saline. To detect lumican, we used
an anti-lumican antibody (R&D Systems, Minneapolis, MN) at a
1:100 dilution. The secondary antibody was anti-goat Alexa Fluor
488 (Invitrogen, Carlsbad, CA) diluted 1:2000. For endothelial
colocalization studies, we used the endothelial-specific lectin
rhodamine Ulex europaeus agglutinin I (Vector Laboratories,
Burlingame, CA) at a dilution of 1:2000. The sections were mounted
using ProLong Gold antifade reagent (Invitrogen) and analyzed
using a confocal microscope, that is, Leica TCS SP5 (Leica
Microsystems GmbH, Wetzler, Germany).
Statistics
SPSS statistics software (SPSS, Chicago, IL) was used for all analyses.
Mann–Whitney’s U-test was used to investigate statistical differences. P
o0.05 was considered to indicate statistical significance.
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